Where are you?

To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.

Media & Investors

Transparency is important to us. Find important information about Kuros Biosciences here – from our corporate documents to our current share price.

Press releases

Click each card below for our latest press releases. For archived news items, please go to our Resources center. To subscribe to receive our press releases, please click here.

11 Sep 2020

Kuros Convenes Extraordinary General Meeting

09 Sep 2020

Kuros Biosciences’s licensee Checkmate Pharmaceuticals completes its IPO on NASDAQ

01 Sep 2020

Kuros Biosciences Announces Treatment of the First Patient in its Spinal Fusion Trial with Fibrin-PTH

12 Aug 2020

Kuros Biosciences Reports Results for First Half 2020

22 Jul 2020

Kuros Biosciences further strengthens orthobiologics patent portfolio

21 Apr 2020

Annual General Meeting of Kuros Biosciences approves all resolutions

Reports & corporate governance

Kuros Biosciences is fully committed to good corporate governance and adherence to high ethical standards. Our principles and rules on corporate governance and ethical conduct are articulated in the Articles of Association, the Internal Regulations, the charters of the committees of our board of directors, and our code of conduct.

Reports & Presentations

Corporate Governance

Regulatory filings

Information on disclosures under the Swiss Stock Exchange Act can be found on the website of the SIX Swiss Exchange website.

Management Transactions

Outstanding Options

Significant Shareholder Transactions



Olav Zilian, MD, PhD, EMBA
Mirabaud Securities Ltd

David Sherman, Ph.D.(AC)
LifeSci Capital

Laura Pfeiffer-Rossi
Octavian AG

Please use the button below to view and download Analyst reports



Date Event
Mar 26, 2020 Kuros will publish its Annual Report for 2019
Apr 21, 2020 Kuros will hold its Annual Shareholders' Meeting
Aug 12, 2020 Kuros will publish its Half Year Report for H1 2020

If you have any questions unanswered by the information on this page, please do let us know